Navigation Links
Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
Date:4/8/2008

CLEVELAND, April 8, 2008 /PRNewswire/ -- Today, Ganeden Biotech announced that Sustenex(TM), its all-natural daily probiotic supplement is now available nationwide. Each Sustenex(TM) capsule contains at least 2 billion live probiotic cells of GanedenBC30, a proprietary, patented strain of Bacillus coagulans designed to help promote immune and digestive fitness. Sustenex(TM) with GanedenBC30 Probiotic is designed to survive and thrive in the digestive tract delivering ten times more probiotic cells than most yogurts.

Immune and Digestive Fitness

According to health and nutrition experts, taking care of the whole body, including the gut, is important to good health and successful aging. Probiotics, or beneficial bacteria, can help counteract insults to the digestive system from poor diet, age, travel, antibiotic use and stress. "Good" and "bad" bacteria maintain a delicate balance in the intestinal tract, which is home to more than 70% of the body's immune system.

"We need to start paying more attention to digestive health," said Steven Pratt, MD, renowned nutrition and lifestyle expert and author of SuperFoods RX and SuperFoods HealthStyle. "Our digestive system is bombarded with insults every day. Eating a healthy diet is critical, but in order to create the right balance of good and bad bacteria in the gut to help build up defenses we need to look at probiotics." According to Dr. Pratt, to get the full benefits of probiotics, look for a supplement that can survive transit through the harsh stomach environment. "Sustenex is a great choice because it contains Bacillus coagulans, a powerful probiotic with a natural protective shell that shields the bacteria from stomach acid as it moves through your digestive system. Probiotics don't work if they don't make it to the gut. Choose one that gets the job done," continued Pratt.

"A daily probiotic supplement helps achieve a balance in the digestive system that we couldn't otherwise meet through diet alone," said Ganeden Nutrition Advisor Susan Davis, MS RD. In terms of probiotic foods, Davis noted that yogurt stands out in consumers' minds. "Many people think they can get all the probiotics they need by eating yogurt, but they're wrong. The live, active cultures in yogurt struggle to make it though the harsh, acidic stomach environment. Probiotics like Bacillus coagulans found in Sustenex(TM) survive and successfully colonize the intestinal tract where they can do the most good," said Davis. "Just like Omega 3s and multi-vitamins, probiotics need to become part of our daily health regimen," Davis continued.

Recently, Dr. Mehmet Oz, M.D. and Dr. Michael Roizen, M.D., authors of the new book YOU: Staying Young, also outlined the importance of having beneficial bacteria in your gut for maintaining digestive and immune health. In YOU: Staying Young, Drs. Oz and Roizen listed a daily dose of 2 billion cells of the probiotic Bacillus coagulans as a choice to consider.

Sustenex

Sustenex(TM), is an all natural daily supplement developed by Ganeden Biotech, containing 2 billion cells of GanedenBC30, which is a patented strain of Bacillus coagulans. GanedenBC30 survives the hostile environment of the stomach, colonizes the intestines, and produces lactic acid, which are all critical components to the success of a probiotic.

"We plan to emphasize the uniqueness of the strain of Bacillus coagulans that we have identified and patented by branding it GanedenBC30 Probiotic," said Ganeden Biotech President Andy Lefkowitz. "The new brand logo will be visible on the Sustenex(TM) package as a clear identifier of our unique GanedenBC30 Probiotic. GanedenBC30 has powered our Digestive Advantage(TM) product line for consumers with particular digestive disorders. By placing it in Sustenex(TM), we're now offering the benefits of GanedenBC30 to consumers interested in probiotics as part of a daily health regimen," continued Lefkowitz.

Ganeden Biotech selected Swardlick Marketing Group, a full-service marketing and communications agency based in Portland, Maine, to lead an integrated marketing campaign in support of the national rollout of Sustenex(TM). The campaign will include advertising, promotion and public relations.

Sustenex(TM) is widely available at Wal-Mart, Walgreens and CVS/pharmacy, select Rite Aid/GNC Live Well(R) stores, Meijer, Longs, Kroger, Stop & Shop, Giant and other retail outlets. Sustenex(TM) is also available online at drugstore.com, amazon.com and other sites. For more information, visit http://www.sustenex.com.

Ganeden Biotech Inc.

Founded in 1997, Ganeden Biotech Inc. is a consumer healthcare company based in Cleveland, Ohio that features a popular line of over-the-counter products under the brand names Sustenex(TM), Digestive Advantage(TM) and Clearly Confident(TM).

Ganeden's oral products, including Sustenex(TM) and Digestive Advantage(TM), contain GanedenBC30 Probiotic, a patented strain of Bacillus coagulans. These probiotics work within the intestinal ecosystem to help support digestive function and maintain digestive health. For more information, visit http://www.ganedenbiotech.com

NOTE: the Food and Drug Administration have not evaluated these statements. This product is not intended to diagnose, treat, cure or prevent any diseases.


'/>"/>
SOURCE Ganeden Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
2. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
3. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
4. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
7. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
8. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
9. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
10. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)...  Wellcentive today announced it has been selected ... -based community care organization (CCO) with more than ... reporting and care management solutions and services. Wellcentive,s ... quality managers, analysts and care managers while providing ... FamilyCare members. Oregon ...
(Date:2/11/2016)... , Feb. 11, 2016   BioInformant announces ... "Stem Cell Research Products, Opportunities, Tools, and Technologies – ... The ... the stem cell industry, BioInformant has more than a ... stem cell market, by stem cell type. This powerful ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... to announce that Mitsui & Co. Ltd., its partner ... acid plant, is investing an additional CDN$25 million in ... its stake from 30% to 40%.  Mitsui will also ... acid produced in Sarnia , providing ...
(Date:2/10/2016)... 2016 ASAE is introducing a hybrid membership ... (AMC) the option of joining or renewing through an ... by staff size, every employee in any size association ... reap all available member benefits.   John ... membership options will allow organizations of any size and ...
Breaking Biology Technology:
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
(Date:1/25/2016)... Unisys Corporation (NYSE: UIS ) today announced the implementation ... New York City , to help U.S. ... the United States using passports that are ... of the system at Dulles last year. The system will ... 2016. --> pilot testing of the system at ...
Breaking Biology News(10 mins):